Eastman Chemical Company (EMN) Barclays 42nd Annual Industrial Select Conference summary

Audience sentiment and market outlook

• Investors showed a generally positive bias toward the stock, with many expecting above-peer EPS growth through the cycle.

• Preferred uses for excess cash were share repurchases and internal investment.

• Most believe the company should trade at a higher multiple, reflecting confidence in future performance.

Macroeconomic and segment performance

• Stable markets like pharma, personal care, and packaging are expected to continue modest growth, while consumer discretionary markets remain challenged.

• No significant improvement is assumed for discretionary segments, but a levered recovery is possible if economic conditions stabilize.

• The U.S. market is seen as more stable compared to Europe and China.

Innovation and operational drivers

• Innovation, especially in the auto sector, is driving above-market growth, with high-value product mix contributing to resilience.

• The methanolysis plant is expected to deliver $75–$100 million in EBITDA, with half from cost savings and half from revenue growth.

• Aggressive cost reduction plans aim for $50 million in operating cost improvement, offsetting inflation and energy headwinds.

• Net EPS growth of 8–8.75% is forecasted, demonstrating the effectiveness of the innovation model.